Ginkgo biloba dry extract (EGb 761®).
Each tablet contains Patented Standardised Ginkgo biloba extract 120mg equivalent to dry leaf 6000mg.
One film-coated tablet contains: 120mg pharmaceutically active component EGb 761, a dry extract from Ginkgo biloba leaves (35-67:1). EGb 761 is standardised to 24% flavone glycosides, 6% terpene lactones & less than 5ppm ginkgolic acids.
1. Improvement of blood circulation and microcirculation by improving the elasticity of red blood cells and vessels.
2. Free radical scavenging.
Improve memory and cognition.
Enhance memory recall and support mental concentration.
Improve tinnitus and vertigo.
The normal dosage is 1 tablet of Tebonin forte 120mg daily. For more intensive use, 1 tablet may be taken twice daily. The intake of Tebonin forte 120mg is independent of meals.
Tebonin forte 120mg should not be used by patients with known hypersensitivity to Ginkgo biloba or to any of the excipients. As there is insufficient data, Tebonin forte 120mg should not be used in children under 18 years of age.
There are no or limited amount of data from the use of Tebonin forte 120mg in pregnant women. As a precautionary measure, it is preferable to avoid the use of Tebonin forte 120mg during pregnancy.
As no sufficient investigations are available, this preparation should not be used during lactation. It is not known whether the extract components are excreted in human milk.
Animal studies do not reveal harmful effects of Tebonin forte 120mg on the fertility.
Single reports indicate the possibility that Ginkgo-containing preparations could increase bleeding tendency. Clinical studies do not give any evidence of an interference with blood coagulation.
Ginkgo may increase the risk of bleeding. Seek medical advice before use if the patient is already taking blood thinning medicines (e.g. aspirin, warfarin) or if the patient has a bleeding tendency.
It cannot be excluded that the application of Ginkgo preparations promotes the occurrence of seizures in epileptic patients.
Patients with rare hereditary galactose intolerance, lactase deficiency or glucose- galactose malabsorption should not take Tebonin forte 120mg.
There are no or limited amount of data from the use of Tebonin forte 120mg in pregnant women. As a precautionary measure, it is preferable to avoid the use of Tebonin forte 120mg during pregnancy.
As no sufficient investigations are available, this preparation should not be used during lactation. It is not known whether the extract components are excreted in human milk.
Animal studies do not reveal harmful effects of Tebonin forte 120mg on the fertility.
There are no verified data on the frequency of the undesirable effects observed during treatment with
Ginkgo biloba-containing preparations, since these undesirable effects have become known through single reports from patients, physicians or pharmacists. According to these reports, the following undesirable effects may occur during treatment with Tebonin forte 120mg.
Gastrointestinal disorders: Mild gastrointestinal disturbances.
Skin and subcutaneous tissue disorders/Immune system disorders: Hypersensitivity reactions.
Nervous system disorders: Headache.
Vascular disorders: Bleeding from single organs has been reported.
N06DX02 - Ginkgo folium ; Belongs to the class of other anti-dementia drugs.
Tebonin Forte FC tab 120 mg
30's
Sign Out
